Noble-3: Triple Agonist Research Overview
Retatrutide represents the next frontier in metabolic study, moving beyond single-receptor (Semaglutide) and dual-receptor (Tirzepatide) models. It targets three pathways simultaneously: GLP-1, GIP, and Glucagon.
Mechanism of Action
-
GLP-1 & GIP: Regulate insulin and appetite.
-
Glucagon: Increases energy expenditure and mitochondrial efficiency.
-
Synergy: The combination is studied for its enhanced impact on lipolysis and metabolic regulation.
Laboratory Specifications
-
-
Purity: ≥ 99% (HPLC/MS Verified)
-
Formula: C223H343N45O69
-
-
Storage:
-
Powder: -20°C (up to 24 months).
-
Reconstituted: 4°C (use within 4 weeks).
-
Best Practices for Reconstitution
To protect the delicate peptide bonds:
-
Slow Dilution: Drip Bacteriostatic Water down the vial wall; do not spray the powder directly.
-
No Shaking: Gently swirl the vial. Shaking causes foaming, which indicates peptide denaturation.
-
Aliquoting: For long-term studies, freeze single-use doses at -20°C to avoid repeated freeze-thaw cycles.
Note: Strictly for in-vitro laboratory research. Not for human consumption. Proper PPE and sharps disposal are required.

Reviews
There are no reviews yet.